News articles from UVA Today.

Q&A: What to Know About Waning Vaccine Effectiveness and Booster Shots

UVA's Dr. William Petri explains the reasoning behind the U.S. government's plan for COVID-19 booster shots, beginning next month.

Study: American Indigenous Ancestry Raises Hispanics' Risk for Omega-3 Deficiency

The nutritional deficit could contribute to heart problems and harmful inflammation. This research will help identify patients at risk.

Can a Heartburn Drug Help Doctors Treat COVID-19?

Researchers from the School of Data Science say an over-the-counter acid reflux medication might hamper some of the most deadly effects of the virus.

Back-to-School in 2021: The School Counselor's Role

Counselor education professor Joseph Williams shares his thoughts on the need for a "whole-child approach," the role of school counselors and how to bring an equity lens to social-emotional learning.

Study: Common Blood Pressure Drugs Could Improve Colorectal Cancer Survival

UVA researchers determined that ACE inhibitors, beta-blockers and thiazide diuretics appear particularly beneficial to patients with colorectal cancer.

Shaping the Future of UVA Research Through 'Grand Challenge' Investments

University leadership has committed between $20 million and $50 million for research in environmental resilience and neuroscience this academic year. Leaders are seeking research ideas that will "move the needle" in addressing global challenges.

How to Avoid Snakebites, and What to Do if You're Bitten

The Blue Ridge Poison Center, which has received more than 85 calls this year about snakebites, shares tips on how to handle them.

Q&A: Why Trauma-Sensitive Teaching Matters Even More in 2021

UVA education professor Tish Jennings shares how classroom practices that prioritize safety and community can help schools meet students' needs this year.

The Analytics Tool Some Employers Are Using to Set Your Return-to-Work Schedule

McIntire professor Peter Gray recently took a deep dive into a popular analytics tool that some organizational leaders are using to help them make decisions about employees returning to work.

In HIV Prevention, Worsening Disparities Among States

A preventative drug has been available for more than a decade, yet public health officials estimate that fewer than 20% of people who would benefit from the drug are actually taking it.